Acquires Herbolab India Pvt. Ltd.

CESC Ventures has executed an agreement to buy 64.63% stake in Herbolab India Pvt. Ltd. for a consideration of Rs 32.17 Cr in cash.

Herbolab's FY19 turnover was a meagre Rs 2 Cr on which optically the sales multiple paid seems to be very high at 25 times. However, there must be some valuable IPR created by this company over its decades of existence which could be in the form of research, manufacturing facilities and/or regulatory approvals which in the hands of an aggressive management can be scaled up quickly.

This acquisition gives CESC Ventures an entry into the fast growing Ayurvedic personal care segment.

Source:
- Company Filing: https://www.bseindia.com/xml-data/corpfiling/AttachHis/912e7c44-4d5f-4701-8f30-4708c6f657b8.pdf
- Dr Vaidya's website & online portal: https://drvaidyas.com/



Privacy policy
Mobile Analytics
Exact weightage will depend on each subscriber’s risk appetite & comfort. However, as a thumb rule, any position size under 3% is little insignificant to move returns at portfolio level whereas beyond 10% it gets riskier from a concentration standpoint. Accordingly, low could indicate 3-4% weightage, medium 5-7% and high 8-10%.
Structural are those portfolio businesses where earnings are relatively stable (less volatility) and further are expected to rise in a steady fashion. Cyclicals are businesses which experience periods of upcycle followed by downcycle and have large variation in their reported earnings based on industry demand and supply. The mix between the two depends on available opportunities and respective valuation of the two pockets.